News & Updates

Pregnant women with inflammatory bowel disease (IBD), especially those with thiopurine exposure, face a heightened risk of intrahepatic cholestasis of pregnancy (ICP), according to the results of a systematic review and meta-analysis.

Treatment with remibrutinib, an oral, highly selective Bruton’s tyrosine kinase inhibitor, improved sleep and daily activities in patients with chronic spontaneous urticaria (CSU), according to two phase III REMIX-1 and -2 studies presented at AAD 2025.

Mothers who conceived after medically assisted reproduction interventions appear to be less likely to have postpartum depression compared with those who conceived spontaneously, as suggested in a study.

For every four young people in Singapore, one has a history of nonsuicidal self-injury (NSSI), as shown in a study.

Treatment with sacubitril-valsartan (SV) demonstrates good tolerability and may provide some benefits to hypertension patients with end-stage kidney disease (ESKD) who are undergoing dialysis, as shown by the results of a recent meta-analysis.

Patients with palmoplantar pustulosis (PPP) treated with apremilast show improvements at week 16, with continued treatment resulting in maintained or further improvement at week 52, according to a study presented at AAD 2025. No new safety concerns have been observed.

The use of therapeutic plasma exchange (PEX) in the management of acute liver failure (ALF) results in better haemodynamic parameters but offers no survival benefit, reports a study.

Treatment with the acetylcholinesterase inhibitor donepezil hydrochloride falls short of improving post–COVID-19 conditions such as fatigue and psychological symptoms, as shown in a study from Japan.